Kymera Therapeutics (KYMR) PT Lowered to $69 at Morgan Stanley

March 22, 2021 9:34 AM EDT
Get Alerts KYMR Hot Sheet
Price: $33.44 -4.43%

Rating Summary:
    4 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE
Morgan Stanley analyst Vikram Purohit lowered the price target on Kymera Therapeutics (NASDAQ: KYMR) to $69.00 (from $74.00) while maintaining a Equalweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change